Details
Stereochemistry | RACEMIC |
Molecular Formula | C15H17ClN2O2 |
Molecular Weight | 292.761 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(C)C(=O)C(OC1=CC=C(Cl)C=C1)N2C=CN=C2
InChI
InChIKey=OWEGWHBOCFMBLP-UHFFFAOYSA-N
InChI=1S/C15H17ClN2O2/c1-15(2,3)13(19)14(18-9-8-17-10-18)20-12-6-4-11(16)5-7-12/h4-10,14H,1-3H3
Molecular Formula | C15H17ClN2O2 |
Molecular Weight | 292.761 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/11534318Curator's Comment: description was created based on several sources, includ
https://en.wikipedia.org/wiki/Climbazole
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11534318
Curator's Comment: description was created based on several sources, includ
https://en.wikipedia.org/wiki/Climbazole
Climbazole is a topical antifungal agent commonly used in the treatment of human fungal skin infections such as dandruff[2] and eczema. Climbazole is an antimycotic agent with a high in vitro and in vivo efficacy against P. ovale. After a 1-week washout and a 4-week treatment the clinical evaluation showed a successful reduction of dandruff under the climbazole 0.65% shampoo, skin redness and itching in 80% of the volunteers and a mild improvement in 20% of the volunteers. The cosmetic acceptability was very good by the majority. It is concluded that the formulation tested is effective in the treatment of moderate to severe dandruff. It is most commonly found as an active ingredient in OTC anti-dandruff and anti-fungal products, including shampoos, lotions and conditioners. May cause localized irritation of the skin with symptoms including redness, rashes and itching
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11534318
shampoo
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9230670
climbazole (CLIM) showed good in vitro activity against M. pachydermatis with the the range of MICs (Minimal Inhibitory Concentration ) was between < 0.06 and 1 ug/ml with an empirical median mean of 0.06 ug/ml;
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:25:28 GMT 2023
by
admin
on
Fri Dec 15 16:25:28 GMT 2023
|
Record UNII |
9N42CW7I54
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C514
Created by
admin on Fri Dec 15 16:25:28 GMT 2023 , Edited by admin on Fri Dec 15 16:25:28 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB06662MIG
Created by
admin on Fri Dec 15 16:25:28 GMT 2023 , Edited by admin on Fri Dec 15 16:25:28 GMT 2023
|
PRIMARY | |||
|
1135600
Created by
admin on Fri Dec 15 16:25:28 GMT 2023 , Edited by admin on Fri Dec 15 16:25:28 GMT 2023
|
PRIMARY | |||
|
4374
Created by
admin on Fri Dec 15 16:25:28 GMT 2023 , Edited by admin on Fri Dec 15 16:25:28 GMT 2023
|
PRIMARY | |||
|
100000084294
Created by
admin on Fri Dec 15 16:25:28 GMT 2023 , Edited by admin on Fri Dec 15 16:25:28 GMT 2023
|
PRIMARY | |||
|
CLIMBAZOLE
Created by
admin on Fri Dec 15 16:25:28 GMT 2023 , Edited by admin on Fri Dec 15 16:25:28 GMT 2023
|
PRIMARY | |||
|
9N42CW7I54
Created by
admin on Fri Dec 15 16:25:28 GMT 2023 , Edited by admin on Fri Dec 15 16:25:28 GMT 2023
|
PRIMARY | |||
|
83499
Created by
admin on Fri Dec 15 16:25:28 GMT 2023 , Edited by admin on Fri Dec 15 16:25:28 GMT 2023
|
PRIMARY | |||
|
C108286
Created by
admin on Fri Dec 15 16:25:28 GMT 2023 , Edited by admin on Fri Dec 15 16:25:28 GMT 2023
|
PRIMARY | |||
|
C78033
Created by
admin on Fri Dec 15 16:25:28 GMT 2023 , Edited by admin on Fri Dec 15 16:25:28 GMT 2023
|
PRIMARY | |||
|
253-775-4
Created by
admin on Fri Dec 15 16:25:28 GMT 2023 , Edited by admin on Fri Dec 15 16:25:28 GMT 2023
|
PRIMARY | |||
|
CHEMBL1437764
Created by
admin on Fri Dec 15 16:25:28 GMT 2023 , Edited by admin on Fri Dec 15 16:25:28 GMT 2023
|
PRIMARY | |||
|
759808
Created by
admin on Fri Dec 15 16:25:28 GMT 2023 , Edited by admin on Fri Dec 15 16:25:28 GMT 2023
|
PRIMARY | |||
|
5064
Created by
admin on Fri Dec 15 16:25:28 GMT 2023 , Edited by admin on Fri Dec 15 16:25:28 GMT 2023
|
PRIMARY | |||
|
DTXSID6046555
Created by
admin on Fri Dec 15 16:25:28 GMT 2023 , Edited by admin on Fri Dec 15 16:25:28 GMT 2023
|
PRIMARY | |||
|
climbazole
Created by
admin on Fri Dec 15 16:25:28 GMT 2023 , Edited by admin on Fri Dec 15 16:25:28 GMT 2023
|
PRIMARY | |||
|
191566
Created by
admin on Fri Dec 15 16:25:28 GMT 2023 , Edited by admin on Fri Dec 15 16:25:28 GMT 2023
|
PRIMARY | RxNorm | ||
|
38083-17-9
Created by
admin on Fri Dec 15 16:25:28 GMT 2023 , Edited by admin on Fri Dec 15 16:25:28 GMT 2023
|
PRIMARY | |||
|
9N42CW7I54
Created by
admin on Fri Dec 15 16:25:28 GMT 2023 , Edited by admin on Fri Dec 15 16:25:28 GMT 2023
|
PRIMARY | |||
|
37907
Created by
admin on Fri Dec 15 16:25:28 GMT 2023 , Edited by admin on Fri Dec 15 16:25:28 GMT 2023
|
PRIMARY | |||
|
DB15580
Created by
admin on Fri Dec 15 16:25:28 GMT 2023 , Edited by admin on Fri Dec 15 16:25:28 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |